ImageneBio, Inc. (IMA)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, ImageneBio, Inc. reported revenue of $800.0K, down 77.1% from the prior year. The company ran a net loss, with a net margin of -5668.6%. It held $152.98M in total assets against $19.84M in total liabilities.
Key ratios (FY2025)
-6056.4%
Operating margin
-5668.6%
Net margin
-34.1%
Return on equity
-77.1%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | $800.0K | $3.50M | $9.16M | $15.62M | $30.98M | $9.19M | — |
| Operating Income | -$48.45M | -$37.00M | -$75.42M | -$70.90M | -$34.14M | -$44.52M | — |
| Net Income | -$45.35M | -$36.57M | -$68.17M | -$68.77M | -$34.12M | -$44.26M | — |
| EPS (Diluted) | $-9.64 | $-22.10 | $-1.63 | $-1.90 | $-1.22 | — | — |
| Total Assets | $152.98M | $15.92M | $192.09M | $172.26M | $247.88M | $168.40M | — |
| Total Liabilities | $19.84M | $17.45M | $22.34M | $25.29M | $40.00M | $63.47M | — |
| Shareholders' Equity | $133.14M | -$160.56M | -$126.11M | $146.97M | $207.88M | -$101.05M | -$61.46M |
| Cash & Equivalents | $94.53M | $12.12M | $119.89M | $59.92M | $232.22M | $162.49M | — |
| Operating Cash Flow | -$47.84M | -$21.32M | -$79.74M | -$74.11M | -$60.25M | -$37.83M | — |
| Capital Expenditures | — | — | $414.0K | $1.43M | $1.76M | $766.0K | — |
| Shares Outstanding | — | 48.26M | 48.26M | 36.26M | 35.98M | 3.10M | — |